Cost-effectiveness analysis of treatment timing considering the future entry of lower-cost generics for hepatitis C

• Yazar: Heath K (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Dove Medical Press, 2018-09-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Katherine Heath1,2 1Mathematical Ecology Research Group, Department of Zoology, University of Oxford, Oxford OX1 3PS, UK; 2New College, Oxford OX1 3BN, UK Background: Cost-benefit analyses are crucial to inform treatment policies, particularly when the cost of patented drugs is very high. The cost o...